Keyphrases
Mesenchymal Stromal Cells
100%
Ischemic Heart Failure
100%
Left Ventricular End-diastolic Volume (LVEDV)
100%
Care Groups
42%
Between-group
42%
Left Ventricular Ejection Fraction
42%
NYHA Class
28%
Self-reported Health
28%
Allogeneic
28%
Heart Failure with Preserved Ejection Fraction (HFpEF)
28%
AIMS™
14%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
14%
Clinical Efficacy
14%
Add-on Therapy
14%
Treatment Allocation
14%
Change from Baseline
14%
Serious Adverse Events
14%
Safety Profile
14%
Volume Change
14%
Intramyocardial Injection
14%
Clinical Safety
14%
Patient Treatment
14%
6-minute Walk Test (6MWT)
14%
Efficacy Profile
14%
Cellular Products
14%
Adipose-derived Stromal Cells
14%
Autologous Cell Therapy
14%
Allogeneic Stem Cell Therapy
14%
Medicine and Dentistry
Heart Failure
100%
Heart Left Ventricle Ejection Fraction
100%
End-Systolic Volume
100%
Mesenchymal Stem Cell
100%
Heart Muscle Ischemia
100%
Care Group
60%
End-Diastolic Volume
40%
New York Heart Association Class
40%
Adverse Event
20%
Adipose Tissue
20%
Stem Cell Therapy
20%
Six Minute Walk Test
20%
Cell Therapy
20%
Add on Therapy
20%